Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biophytis

Clinical trials sponsored by Biophytis, explained in plain language.

Biophytis BPTS NASDAQ

A clinical-stage biotech developing therapies for age-related diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Terminated 1

Can a new drug shield lungs from COVID-19's worst damage?

Disease control Terminated

This trial tests whether an experimental drug called BIO101 can prevent severe breathing problems in hospitalized adults with COVID-19 pneumonia. Participants receive either BIO101 or a placebo for 28 days, and researchers track who develops respiratory failure, needs high-flow o…

Phase: PHASE2, PHASE3 • Sponsor: Biophytis • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC